Amrize Stock Performance
| AMRZ Stock | 54.53 0.01 0.02% |
Amrize has a performance score of 8 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.53, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amrize will likely underperform. Amrize right now shows a risk of 1.82%. Please confirm Amrize value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Amrize will be following its price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Amrize are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Amrize may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
Actual Historical Performance (%)
One Day Return 0.0275 | Five Day Return (4.38) | Year To Date Return (1.62) | Ten Year Return 4.89 | All Time Return 4.89 |
1 | Acquisition by Roald Brouwer of 3000 shares of Amrize at 51.78 subject to Rule 16b-3 | 10/31/2025 |
2 | Will Amrizes Bold MA Flexibility Redefine Its Growth Trajectory - simplywall.st | 11/07/2025 |
3 | River Road Asset Management LLC Buys Shares of 826,587 Amrize Ltd AMRZ - MarketBeat | 12/02/2025 |
4 | Gamco Investors INC. ET AL Purchases Shares of 40,384 Amrize Ltd AMRZ | 12/11/2025 |
5 | Amrize Expands Production Capacity at Flagship U.S. Cement Plant | 12/16/2025 |
6 | Head to Head Analysis Amrize versus PT Semen Indonesia Tbk | 01/02/2026 |
7 | Truist Financial Maintains Amrize With Buy Rating - | 01/08/2026 |
8 | Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesdays Pre-Market Session - Benzinga | 01/13/2026 |
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | -1.2 B |
Amrize Relative Risk vs. Return Landscape
If you would invest 4,879 in Amrize on October 20, 2025 and sell it today you would earn a total of 574.00 from holding Amrize or generate 11.76% return on investment over 90 days. Amrize is currently generating 0.1929% in daily expected returns and assumes 1.8195% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of stocks are less volatile than Amrize, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amrize Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amrize's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amrize, and traders can use it to determine the average amount a Amrize's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.106
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AMRZ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Amrize is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amrize by adding it to a well-diversified portfolio.
Amrize Fundamentals Growth
Amrize Stock prices reflect investors' perceptions of the future prospects and financial health of Amrize, and Amrize fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amrize Stock performance.
| Profit Margin | 0.11 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 33.58 B | ||||
| Shares Outstanding | 552.74 M | ||||
| Price To Book | 2.20 X | ||||
| Price To Sales | 2.36 X | ||||
| Revenue | 11.7 B | ||||
| Gross Profit | 3.02 B | ||||
| EBITDA | 3.01 B | ||||
| Net Income | 1.27 B | ||||
| Total Debt | 5.79 B | ||||
| Book Value Per Share | 17.20 X | ||||
| Cash Flow From Operations | 2.28 B | ||||
| Earnings Per Share | 2.55 X | ||||
| Market Capitalization | 27.46 B | ||||
| Total Asset | 23.8 B | ||||
| Working Capital | 2.06 B | ||||
About Amrize Performance
Evaluating Amrize's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Amrize has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amrize has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 55.24 | 45.13 | |
| Return On Tangible Assets | 0.10 | 0.08 | |
| Return On Capital Employed | 0.09 | 0.08 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.13 | 0.10 |
Things to note about Amrize performance evaluation
Checking the ongoing alerts about Amrize for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amrize help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amrize has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesdays Pre-Market Session - Benzinga |
- Analyzing Amrize's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amrize's stock is overvalued or undervalued compared to its peers.
- Examining Amrize's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amrize's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amrize's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amrize's stock. These opinions can provide insight into Amrize's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Amrize Stock Analysis
When running Amrize's price analysis, check to measure Amrize's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amrize is operating at the current time. Most of Amrize's value examination focuses on studying past and present price action to predict the probability of Amrize's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amrize's price. Additionally, you may evaluate how the addition of Amrize to your portfolios can decrease your overall portfolio volatility.